JPRN-UMIN000049928招募中Unknown
A prospective observational study of nivolumab plus chemotherapy for advanced gastric cancer using CyberOncology (WJOG15922G) - PROCEED
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Concomitant active malignancies within 3 years prior to registration 2) Active autoimmune disease 3) Requiring systemic corticosteroid or immunosuppressant within 14 days prior to registration 4) Active infection under treatment 5) Pregnant or lactating female 6) Uncontrolled psychiatry disease 7) History of serious allergic reactions 8) Judged inappropriate by the investigators
研究者
相似试验
进行中（未招募）
1 期
A study of nivolumab alone, or in combination with vinblastin in patients aged 61 years and older, with Hodgkin Lymphomapatients aged 61 years and older, with classical Hodgkin lymphoma and coexisting medical conditionsMedDRA version: 20.1Level: LLTClassification code 10080208Term: Classical Hodgkin lymphomaSystem Organ Class: 100000004864EUCTR2017-001939-38-FRYSARC64
进行中（未招募）
1 期
A study of nivolumab alone, or in combination with vinblastin in patients aged 61 years and older, with Hodgkin Lymphomapatients aged 61 years and older, with classical Hodgkin lymphoma and coexisting medical conditionsMedDRA version: 20.1Level: LLTClassification code 10080208Term: Classical Hodgkin lymphomaSystem Organ Class: 100000004864EUCTR2017-001939-38-BEYSARC64
招募中
不适用
observational/translational study for nivolumab treatment in advanced esophageal canceresophageal cancerJPRN-UMIN000043208Hokkaido Gastrointestinal Cancer Study Group25
进行中（未招募）
1 期
A randomized, run-in, phase II study of nivolumab combined with ipilimumab and guadecitabine or nivolumab combined with ipilimumab in melanoma and NSCLC patients resistant to anti-PD-1/PD-L1MM and NSCLC patients resistant to anti-PD-1/PD-L1 therapyMedDRA version: 20.0Level: SOCClassification code 10029104Term: Neoplasms benign, malignant and unspecified (incl cysts and polyps)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2019-002986-36-ITFONDAZIONE NIBIT NETWORK ITALIANO PER LA BIOTERAPIA DEI TUMORI184
已完成
2 期
A clinical trial of nivolumab in patients with unresectable clear cell sarcoma and alveolar soft part sarcoma (NCCH1510,OSCAR trial)clear cell sarcoma and alveolar soft part sarcomaJPRN-UMIN000023665ational Cancer Center20